Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose rabeprazole versus omeprazole in obese subjects
2010-018875-30Phase 2Active
- Sponsor
- CHU de Nantes
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of rabeprazole and omeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by CHU de Nantes. Started Mar 2010; status: active.
02
Drugs
rabeprazoleomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2010-018875-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018875-30.